Innate Pharma Stock Price History

IPHA Stock  USD 1.79  0.03  1.70%   
If you're considering investing in Innate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Innate Pharma stands at 1.79, as last reported on the 31st of January, with the highest price reaching 1.81 and the lowest price hitting 1.74 during the day. Innate Pharma appears to be abnormally volatile, given 3 months investment horizon. Innate Pharma holds Efficiency (Sharpe) Ratio of 0.0476, which attests that the entity had a 0.0476 % return per unit of risk over the last 3 months. By evaluating Innate Pharma's technical indicators, you can evaluate if the expected return of 0.68% is justified by implied risk. Please utilize Innate Pharma's Risk Adjusted Performance of 0.0492, downside deviation of 7.64, and Market Risk Adjusted Performance of 1.21 to validate if our risk estimates are consistent with your expectations.
  
Innate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0476

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsIPHA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 14.22
  actual daily
96
96% of assets are less volatile

Expected Return

 0.68
  actual daily
13
87% of assets have higher returns

Risk-Adjusted Return

 0.05
  actual daily
3
97% of assets perform better
Based on monthly moving average Innate Pharma is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Innate Pharma by adding it to a well-diversified portfolio.

Innate Pharma Stock Price History Chart

There are several ways to analyze Innate Stock price data. The simplest method is using a basic Innate candlestick price chart, which shows Innate Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 13, 20243.02
Lowest PriceNovember 15, 20241.44

Innate Pharma January 31, 2025 Stock Price Synopsis

Various analyses of Innate Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Innate Stock. It can be used to describe the percentage change in the price of Innate Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Innate Stock.
Innate Pharma Price Daily Balance Of Power 0.43 
Innate Pharma Price Rate Of Daily Change 1.02 
Innate Pharma Price Action Indicator 0.03 

Innate Pharma January 31, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Innate Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Innate Pharma intraday prices and daily technical indicators to check the level of noise trading in Innate Stock and then apply it to test your longer-term investment strategies against Innate.

Innate Stock Price History Data

The price series of Innate Pharma for the period between Sat, Nov 2, 2024 and Fri, Jan 31, 2025 has a statistical range of 1.58 with a coefficient of variation of 14.82. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.8. The median price for the last 90 days is 1.79.
OpenHighLowCloseVolume
01/31/2025
 1.76  1.81  1.74  1.79 
01/30/2025 1.76  1.81  1.74  1.79  15,348 
01/29/2025 1.74  1.80  1.71  1.76  21,796 
01/28/2025 1.77  1.83  1.70  1.76  45,581 
01/27/2025 1.85  1.92  1.70  1.80  385,400 
01/24/2025 1.75  1.77  1.67  1.77  20,437 
01/23/2025 1.74  1.74  1.63  1.67  21,083 
01/22/2025 1.78  1.78  1.76  1.77  4,614 
01/21/2025 1.74  1.77  1.74  1.77  11,492 
01/17/2025 1.73  1.74  1.65  1.69  13,723 
01/16/2025 1.73  1.75  1.67  1.67  31,476 
01/15/2025 1.80  1.80  1.60  1.70  100,189 
01/14/2025 1.82  1.83  1.75  1.79  12,198 
01/13/2025 1.79  1.87  1.78  1.82  29,616 
01/10/2025 1.83  1.83  1.74  1.77  74,986 
01/08/2025 1.87  1.87  1.64  1.83  38,403 
01/07/2025 1.89  1.89  1.83  1.86  15,159 
01/06/2025 1.92  1.95  1.85  1.88  80,226 
01/03/2025 1.90  1.94  1.80  1.87  25,676 
01/02/2025 1.94  1.94  1.87  1.87  38,367 
12/31/2024 1.94  1.96  1.77  1.84  49,365 
12/30/2024 2.09  2.09  1.81  1.95  101,583 
12/27/2024 2.11  2.14  2.04  2.11  33,408 
12/26/2024 2.07  2.12  2.03  2.11  41,712 
12/24/2024 2.06  2.08  2.03  2.06  24,122 
12/23/2024 2.04  2.15  2.01  2.10  37,962 
12/20/2024 2.08  2.10  2.03  2.05  48,484 
12/19/2024 2.15  2.18  2.08  2.16  43,751 
12/18/2024 2.19  2.36  2.11  2.16  156,594 
12/17/2024 2.12  2.31  2.12  2.15  196,236 
12/16/2024 2.44  2.67  2.07  2.37  957,982 
12/13/2024 1.50  3.51  1.47  3.02  13,573,101 
12/12/2024 1.57  1.64  1.54  1.55  126,246 
12/11/2024 1.66  1.73  1.52  1.69  301,555 
12/10/2024 1.80  1.85  1.65  1.80  760,334 
12/09/2024 1.84  1.94  1.57  1.90  13,078,896 
12/06/2024 1.62  1.62  1.43  1.47  40,950 
12/05/2024 1.46  1.46  1.43  1.45  21,634 
12/04/2024 1.51  1.51  1.41  1.45  14,900 
12/03/2024 1.51  1.51  1.51  1.51  512.00 
12/02/2024 1.56  1.56  1.45  1.46  10,711 
11/29/2024 1.49  1.55  1.49  1.54  3,508 
11/27/2024 1.59  1.59  1.50  1.50  6,902 
11/26/2024 1.48  1.50  1.48  1.50  9,682 
11/25/2024 1.56  1.57  1.45  1.45  69,405 
11/22/2024 1.60  1.70  1.54  1.63  7,993 
11/21/2024 1.65  1.70  1.56  1.70  1,303 
11/20/2024 1.60  1.70  1.60  1.69  7,669 
11/19/2024 1.55  1.61  1.48  1.49  11,599 
11/18/2024 1.45  1.66  1.29  1.53  41,648 
11/15/2024 1.60  1.66  1.44  1.44  20,125 
11/14/2024 1.65  1.68  1.62  1.67  5,758 
11/13/2024 1.70  1.70  1.68  1.68  4,018 
11/12/2024 1.75  1.91  1.75  1.90  8,941 
11/11/2024 1.69  2.00  1.68  1.85  7,438 
11/08/2024 1.57  1.87  1.57  1.84  7,075 
11/07/2024 1.82  1.85  1.71  1.84  3,848 
11/06/2024 2.06  2.06  2.06  2.06  348.00 
11/05/2024 1.73  1.78  1.73  1.78  4,049 
11/04/2024 1.94  1.94  1.80  1.83  2,136 
11/01/2024 1.83  1.91  1.83  1.88  6,627 

About Innate Pharma Stock history

Innate Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Innate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Innate Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Innate Pharma stock prices may prove useful in developing a viable investing in Innate Pharma
Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company was incorporated in 1999 and is headquartered in Marseille, France. Innate Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 213 people.

Innate Pharma Stock Technical Analysis

Innate Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Innate Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Innate Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Innate Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Innate Pharma's price direction in advance. Along with the technical and fundamental analysis of Innate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Innate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Innate Stock analysis

When running Innate Pharma's price analysis, check to measure Innate Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innate Pharma is operating at the current time. Most of Innate Pharma's value examination focuses on studying past and present price action to predict the probability of Innate Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innate Pharma's price. Additionally, you may evaluate how the addition of Innate Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments